These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24020909)

  • 1. Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study.
    Di Carlo C; Gargano V; Sparice S; Tommaselli GA; Bifulco G; Nappi C
    Gynecol Endocrinol; 2013 Dec; 29(12):1048-50. PubMed ID: 24020909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
    Raps M; Rosendaal F; Ballieux B; Rosing J; Thomassen S; Helmerhorst F; van Vliet H
    J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.
    De Leo V; Fruzzetti F; Musacchio MC; Scolaro V; Di Sabatino A; Morgante G
    Contraception; 2013 Sep; 88(3):364-8. PubMed ID: 23769016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol valerate/dienogest: a novel combined oral contraceptive.
    Borgelt LM; Martell CW
    Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
    Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
    Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
    Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
    Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
    Caruso S; Agnello C; Romano M; Cianci S; Lo Presti L; Malandrino C; Cianci A
    J Sex Med; 2011 Oct; 8(10):2841-50. PubMed ID: 21810188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
    Palombo-Kinne E; Schellschmidt I; Schumacher U; Gräser T
    Contraception; 2009 Apr; 79(4):282-9. PubMed ID: 19272497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
    Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
    Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome.
    Morgante G; Cappelli V; Troìa L; De Leo V
    Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):176-181. PubMed ID: 32191532
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluation.
    Colonna L; Pacifico V; Lello S; Sorge R; Raskovic D; Primavera G
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1364-71. PubMed ID: 22011217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
    Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
    Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest.
    Fraser IS; Jensen J; Schaefers M; Mellinger U; Parke S; Serrani M
    Contraception; 2012 Aug; 86(2):96-101. PubMed ID: 22240178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
    Sänger N; Stahlberg S; Manthey T; Mittmann K; Mellinger U; Lange E; Kuhl H; Wiegratz I
    Contraception; 2008 Jun; 77(6):420-5. PubMed ID: 18477491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest.
    Zeun S; Lu M; Uddin A; Zeiler B; Morrison D; Blode H
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):221-32. PubMed ID: 19565420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHBG, testosterone, androstenedione, 17-OH-Progesterone plasma levels in PCO affected women treated with a triphasic oral contraceptive.
    Negri P; Agnello G; Borghesani F; Tomain L; Minisci N; D'Errico G; Cavallini AR
    Acta Eur Fertil; 1987; 18(6):375-80. PubMed ID: 3454501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol valerate/dienogest: a novel oral contraceptive.
    Whalen KL; Rose R
    Ann Pharmacother; 2011 Oct; 45(10):1256-61. PubMed ID: 21917554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
    Saletu B
    Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.